Table 2.
Gene | Model | N taxa | N sites |
---|---|---|---|
12S rRNA [mtDNA] |
GTR+I+Γ |
391 |
724 |
Breast and ovarian cancer susceptibility protein exon 11 (BRCA1) [nucDNA] |
TVM+I+Γ |
99 |
2977 |
Control region (DLOOP) [mtDNA] |
HKY+I+Γ |
45 |
996 |
Cytochrome oxydase 3 (COX3) [mtDNA] |
GTR+I+Γ |
105 |
784 |
Cytochrome b (CYTB) [mtDNA] |
GTR+I+Γ |
1152 |
1140 |
Interphotoreceptor retinoid-binding protein exon 1 (RBP3) [nucDNA] |
GTR+I+Γ |
536 |
1302 |
Growth hormone receptor (GHR) exon 10 [nucDNA] |
HKY+I+Γ |
282 |
974 |
NADH dehydrogenase 4 (NADH4) [mtDNA] |
GTR+I+Γ |
99 |
1389 |
NADH dehydrogenase 1 (NADH1) [mtDNA] |
TVM+I+Γ |
45 |
961 |
Recombination activating protein 1 exon 1 (RAG1) [nucDNA] |
GTR+I+Γ |
238 |
3044 |
von Willebrand gene (vWF) exon 28 [nucDNA] | TrN+I+Γ | 110 | 1272 |
The abbreviated models are the following: HKY: Hasegawa, Kishino, Yano [79]; GTR: General Time Reversible [80,81]; TrN: Tamura-Nei [82]; TVM: Transversion Model; + Γ: variation in rates among sites modeled using a gamma distribution [83]; +I; a proportion of sites modeled as invariant [79]. N taxa = number of available taxa on public databases. N sites = Number of aligned nucleotides.